О.Баатархүү
Loading...
Товч нэр
О.Баатархүү
Бүтэн нэр
Ойдов Баатархүү
Латин нэр
Baatarkhuu Oidov
Эрдмийн цол
Профессор
Боловсролын зэрэг
Доктор (Ph.D)
Харьяалал
ORCID
Scopus Author ID
30 results
Now showing 1 - 10 of 30
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Need for continuing medical education for liver disease management in Mongolia(Elsevier BV, 2016-08-20) ;Youlim Kim ;Anh Hai Le ;Jacqueline Estevez ;Dennis M Israelskirefugee and UNHCR supervised by.Rest of the refugees called undocumented Myanmar nationals (UMNs) lives in cluster settlements.While registered residents have access to basic services, those UMNs do not.They have limited access to maternal and newborn health (MNH) services.A study was conducted to ascertain existing MNH situation of UMNs.Methods: Cross sectional descriptive study was carried out in 2015.23,466 households covering 105,600 populations from three subdistricts of Cox's Bazar were screened and 279 UMN women and 1858 Bangladeshi women having one under 1 year old child was randomly selected from both rural and urban areas.Findings: UMN respondents, went to unqualified private practitioners, was 58.8%.34.1% made four ANC visits and 16.5 % did not receive any. 61.6% UMN women received Tetanus Toxoid.Respondents who had no knowledge about any danger sign related to pregnancy and delivery, and newborn danger sign were 10.4% and 9.7%, respectively.71.7% UMNs had no knowledge about transmission of HIV/AIDS.84.6% UMN respondents gave birth at home, among them 43.7% were conducted by untrained Traditional Birth Attendants.48.7% did not seek immediate health check-up after home delivery.33.5% of home delivered newborns' cord was cut with delivery kit blade.35.8% newborn was dried and 10.8% wrapped immediate after home delivery.Almost half of the babies were bathed within one hour of birth.74.9% of UMN mother initiated breast feeding within 30 minutes.53.7% of UMN respondents used contraceptives and half of them used injectable methods.Interpretation: The study revealed that knowledge and health seeking behavior on MNH services of UMN women was poor.The majority sought health care from unqualified practitioners.Coverage of ANC visit and postnatal check-up was low.Deliveries assisted by medically trained personnel were very low among the UMNs.The immediate newborn care was not up-to the level.Contraceptive use of women was not satisfactory. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Detection of Common Bacterial Causes of STIs among STD Clinic Attendees by Gram Stain and Culture versus the Microarray Nucleic Acid Hybridization Method(Mongolian National University of Medical Sciences, 2017-06-25); ;Bulbul Aumakhan; ;Unursaikhan GanbatErdenechimeg ChoijiljavObjectives: The purpose of the study was to determine the prevalence and etiology of predominant sexually transmitted infections (STIs) occurring among the STD and Gynecology Clinic attendees and to compare sensitivity and specificity of conventional versus molecular diagnostic methods. Methods: A total of 1,441 individuals were recruited from the STD clinic at the National Center for Communicable Diseases and Gynecology Clinic at the National Center for Oncology between 2014 and 2015. Urogenital tract swab samples were collected and tested for N.gonorrhoeae, C.trachomatis, and T.vaginalis using conventional (Gram stain and culture) and molecular (Microarray Nucleic Acid Hybridization - MNAHM) diagnostic methods. The final infection status of participants was determined using the “either test positive” strategy. Results: Of the total 1,441 participants, 19.7% were N.gonorrhoeae infected, 12.5% were C.trachomatis infected, and 7.8% were T.vaginalis infected. For T. vaginalis, conventional methods and MNAHM had sensitivities of 17.9% and 98.2%, with specificities of 96.6% and 99.6%, respectively. For N.gonorrhoeae, conventional methods had sensitivity and specificity values of 33.3% and 99.1%, and MNAHM had values of 95.1% and 98.8%, respectively. Conclusion: The study found a high prevalence of N.gonorrhoeae and C.trachomatis among STD and Gynecology Clinic attendees. Conventional methods for detection of N.gonorrhoeae and T.vaginalis were significantly less sensitive than molecular diagnostic methods and didn’t detect other STI pathogens. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Viral Hepatitis and Liver Diseases in Mongolia(Jaypee Brothers Medical Publishing, 2017-06-01); ;Uugantsetseg, G ;Munkh-Orshikh, D ;Naranzul, NBadamjav, S - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Comparison of Adverse Events Between Selective Internal Radiation Therapy Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma in Mongolia: A Subgroup Analysis of SIRveNIB Study(Mongolian National University of Medical Sciences, 2017-11-25); ; ;Bolormaa Yalhgar ;Tuyatsetseg AltankhuyagObjective: This study compared the adverse events associated with selective internal radiation therapy to sorafenib in the treatment of patients with locally advanced hepatocellular carcinoma (HCC). Methods: From March 2011 to June 2106, the National Cancer Center of Mongolia recruited 39 patients from Mongolia (19 received sorafenib and 20 received SIRT in Singapore) with advanced hepatocellular carcinoma who had not received surgical therapy into a multicenter study involving a total of 360 patients at 27 sites in 11 Asia-Pacific countries. The study was a phase III randomized-controlled clinical trial comparing sorafenib or SIRT. Results: Adverse events for patients receiving sorafenib were predominantly grade 1 or 2 in gastrointestinal, constitutional and dermatologic in nature. The most frequently reported drug-related adverse events in patients treated with sorafenib were hypertension, hand-foot skin reaction, diarrhea, alopecia, fatigue. Common procedure-related adverse events were usually mild (grade 1/2) and included nausea and vomiting (27.7% all grades) and abdominal pain (22.1% all grades), with very few grades 3 or greater adverse events. Conclusion: In our analysis of 39 patients, we were unable to detect a statistically significant difference in adverse effects between sorafenib and SIRT treatment groups, likely because there were insufficient number patients in our study. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Epidemiology, Genotype Distribution, Prognosis, Control, and Management of Viral Hepatitis B, C, D, and Hepatocellular Carcinoma in Mongolia(2018); ; ;Munkh-Orshikh, Dashchirev; Sarangua, GanboldMongolia is located between Russia and China. The total population of Mongolia as of December 2017 is estimated to be 3.2 million people. According to our previous study results, the prevalence of HBV was 11.8%, and anti-HDV was detected in 4.8% among the HBsAg-positive subjects. Interestingly, most HCV infection is caused by genotype 1b. Among all HBV DNA-positive samples, 98.5% were classified into genotype D, and regarding HDV genotypes, all HDV RNA-positive samples, 100%, were classified into genotype I. The second study is the baseline survey of a Nationwide Cancer Cohort Study. Prevalence of HBsAg was 10.6%. Additionally, HCV infection was observed in 9.9%, and 0.8% were coinfected with HBV and HCV among the general population aged from 10 to 64 years. The third study investigated the population-based prevalence of hepatitis B and C virus in apparently healthy population of Ulaanbaatar city, Mongolia. The anti-HCV prevalence was 9.0%. In addition, the prevalence of HBV was 8.0%. The fourth study is on the prevalence of HCV and coinfections among nurses in a tertiary hospital in Mongolia. The prevalence of HCV was 18.9%. Additionally, HBV infection was observed in 23.1%, and 1.2% were coinfected with HCV and HBV. Mongolia has the highest HCC incidence in the world (78.1/100,000, 3.5* higher than China). As a result, the Mongolia government has launched The National Viral Hepatitis Program, which is a comprehensive program that involves all aspects from prevention to care and disease control to meet a reduction goal for morbidity and mortality due to HBV, HCV, and HDV. Consequently, access to antiviral therapies is now improving in Mongolia. How to cite this article: Baatarkhuu O, Gerelchimeg T, Munkh-Orshikh D, Batsukh B, Sarangua G, Amarsanaa J. Epidemiology, Genotype Distribution, Prognosis, Control, and Management of Viral Hepatitis B, C, D, and Hepatocellular Carcinoma in Mongolia. Euroasian J Hepato-Gastroenterol 2018;8(1):57-62. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, CLINICAL AND EPIDEMIOLOGICAL MANIFESTATION OF HEPATOCELLULAR CARCINOMA IN PATIENTS BELONGING TO ETHNIC GROUPS OF CAUCASIANS AND ASIANS OF NORTH-EAST ASIA(Central Research Institute for Epidemiology, 2018-12-28) ;Yuschuk, N. D. ;Malov, I. V.; ;Savilov, E. D.Malov, S. I. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Mongolian Patients with Advanced Hepatocellular Carcinoma: A Subgroup Analysis of the SIRveNIB Study(Mongolian National University of Medical Sciences, 2019-09-25); ;Sanduijav Rubjir ;Baasanjav NachinObjective: The purpose of this study was to compare the efficacy and safety of selective internal radiation therapy and sorafenib on advanced hepatocellular carcinoma. Methods: The National Cancer Center of Mongolia was one of the Asia-Pacific Liver Cancer Research Team sites, and we recruited patients into the study. Patients were randomly assigned 1:1 stratified and to receive either SIRT or sorafenib 800 mg/d orally. Outcome measures were physical examination, functional assessment, CBC, liver function test, AFP results, and CT scan every 4, 8 and, 12 weeks after treatment initiation. Results: Between March 2011 and June 2016, 39 patients were enrolled in the study. Twenty patients were treated with SIRT, and 19 patients were treated with sorafenib. Median OS and PFS rates were no different in sorafenib arm patients than in SIRT arm (15.56 vs. 9.17; HR 0.95, 95% CI 0.46, p = .889) and (8.51 months vs. 5.85 months; HR,1.07; CI, 0.53-2.16, p = .842). But, tumor response was greater in SIRT than sorafenib treatment (68.8% vs 62.5%, p = .033). Two (10%) patients had a complete response, 2 (10%) patients had a partial response, and 7 (43.8%) patients had a stable response. A total of 165 treatment-emergent adverse events were reported (SIRT 66 vs. sorafenib 99). Significantly fewer patients in the SIRT than sorafenib group had grade ≥3 adverse events (83 vs. 115, p = .0964). Conclusion: In patients with locally advanced hepatocellular carcinoma, overall survival did not differ significantly between SIRT and sorafenib. But SIRT significantly increased tumor response and reduced the incidence of adverse events compared with sorafenib. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals(Springer Science and Business Media LLC, 2019-02) ;Lee, Hye Won ;Kim, Seung Up; ;Park, Jun YongRoutine nucleos(t)ide analogs (NUCs) have not yet been recommended for patients with immune-tolerant (IT) phase in chronic hepatitis B virus (HBV) infection. We aimed to evaluate prognosis of patients in untreated IT-phase (UIT group), compared to those in immune-active phase who achieved virological response by NUCs according to guidelines (VR group). Between 2006 and 2012, patients in UIT or VR groups were included. Cumulative risks of HCC and liver-related events (LREs) development were assessed. Furthermore, propensity-score was calculated based upon age, gender, diabetes and liver stiffness. UIT group (n = 126) showed younger age, lower proportion of male gender and lower LS than VR group (n = 641). UIT group had similar 10-year cumulative risks of HCC (2.7% vs. 2.9%, p = 0.704) and LRE (4.6% vs. 6.1%, p = 0.903) development, compared to VR group. When we re-defined UIT group by the lower ALT cut-offs, 10-year cumulative risks of HCC and LRE development were 2.9% and 4.8%, respectively. Using propensity-score matching and inverse probability treatment weighting analysis, similar results were reproduced. UIT group consistently had similar prognosis compared to VR group. Therefore, further large-scale prospective studies in order to verify rationales of routine NUCs in UIT group are still required.Scopus© Citations 31 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B(The Korean Association for the Study of the Liver, 2013) ;Park, Mi Sung ;Kim, Beom Kyung ;Kim, Kyung Sik ;Kim, Ja KyungKim, Seung UpScopus© Citations 10 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm – volume 2(Wiley, 2015-01) ;Hatzakis, A. ;Chulanov, V. ;Gadano, A. C. ;Bergin, C.Ben‐Ari, Z.Scopus© Citations 118
